Stay updated with breaking news from Additional Information Will. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Acquires F351, a Phase 3 Drug to Treat Fibrosis Will Acquire Controlling Interest in Continent, a China-Based Commercial Pharma Company, from the GNI Group in Subsequent Transaction Announces $7.5
/PRNewswire/ -- Disc Medicine, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for...
/PRNewswire/ -- Disc Medicine, a clinical-stage biotechnology company dedicated to the discovery and development of novel therapeutic candidates for the...
Secured Initial Volume Order from Siemens Mobility for the Class I Rail 900 MHz NetworkEntered into Definitive Merger Agreement to Acquire Airobotics, a Leading Developer of Autonomous Drone SystemsConference
BASKING RIDGE, N.J. and SAN DIEGO, July 06, 2022 -- Caladrius Biosciences, Inc. , a clinical-stage biopharmaceutical company developing innovative therapies designed to treat or reverse... | July 6, 2022